Publications
A multicenter randomized controlled trial to evaluate the efficacy and safety of nelfinavir in patients with mild COVID-19
Miyazaki, T., Hosogaya, N., Fukushige, Y., Takemori, S., Morimoto, S., Yamamoto, H., Hori, M., Ozawa, Y., Shiko, Y., Inaba, Y., Kurokawa, T., Hanaoka, H., Iwanami, S., Kim, K., Iwami, S., Watashi, K., Miyazawa, K., Umeyama, T., Yamagoe, S., … Kohno, S. (2023). Microbiology Spectrum, 11(3).
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1.
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Sakai-Tagawa, Y., Furusawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kashima, Y., Kikuchi, T., Yotsuyanagi, H., Suzuki, Y., & Kawaoka, Y. (2023). The Lancet. Infectious Diseases, 23(5), 525-526.
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.
Scott, N., Pearmain, L., Knight, S., Brand, O., Morgan, D., Jagger, C., Harbach, S., Khan, S., Shuwa, H., Franklin, M., Kästele, V., Williams, T., Prise, I., McClure, F., Hackney, P., Smith, L., Menon, M., Konkel, J., Lawless, C., … Mann, E. (2023). The European Respiratory Journal, 61(5), 2202226.
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate.
Uraki, R., Ito, M., Kiso, M., Yamayoshi, S., Iwatsuki-Horimoto, K., Furusawa, Y., Sakai-Tagawa, Y., Imai, M., Koga, M., Yamamoto, S., Adachi, E., Saito, M., Tsutsumi, T., Otani, A., Kikuchi, T., Yotsuyanagi, H., Halfmann, P., Pekosz, A., & Kawaoka, Y. (2023). The Lancet. Infectious Diseases, 23(4), 402-403.
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling, W., Jittamala, P., Watson, J., Ekkapongpisit, M., Siripoon, T., Ngamprasertchai, T., Luvira, V., Pongwilai, S., Cruz, C., Callery, J., Boyd, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Piaraksa, N., Suwannasin, K., Hanboonkunupakarn, P., Hanboonkunupakarn, B., … White, N. (2023). ELife, 12.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia
Ikeda, M., Okugawa, S., Kashiwabara, K., Moritoyo, T., Kanno, Y., Jubishi, D., Hashimoto, H., Okamoto, K., Tsushima, K., Uchida, Y., Mitsumura, T., Igari, H., Tsutsumi, T., Araoka, H., Yatera, K., Yamamoto, Y., Nakamura, Y., Otani, A., Yamashita, M., … Moriya, K. (2023). International Journal of Infectious Diseases, 128, 355-363.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open- label, randomised, controlled adaptive platform trial
Luvira, V., Schilling, W., Jittamala, P., Watson, J., Boyd, S., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Singh, S., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Keayarsa, S., Madmanee, W., … White, N. (2023). In Research Square.
Outbreaks of COVID-19 in a tuberculosis treatment sanatorium on the Thailand-Myanmar border: a retrospective cohort analysis.
Aung, H., Swe, L., Saito, M., Lesseps, S., Janurian, N., Tun, W., Maung Maung, B., Than, A., Watthanaworawit, W., Kaewphanderm, N., Gornsawun, G., Pyae Phyo, A., & Nosten, F. (2023). Wellcome Open Research, 8, 272.
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta- analysis (vol 2, e000561, 2022)
Guerin, P., McLean, A., Rashan, S., Lawal, A., Watson, J., & Strub-Wourgaft, N. (2023). PLOS GLOBAL PUBLIC HEALTH, 3(4).
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
Takashita, E., Yamayoshi, S., Halfmann, P., Wilson, N., Ries, H., Richardson, A., Bobholz, M., Vuyk, W., Maddox, R., Baker, D., Friedrich, T., O’Connor, D., Uraki, R., Ito, M., Sakai-Tagawa, Y., Adachi, E., Saito, M., Koga, M., Tsutsumi, T., … Kawaoka, Y. (2022). The New England Journal of Medicine, 387(22), 2094-2097.
Association of body mass index with COVID-19 related in-hospital death.
Bouziotis, J., Arvanitakis, M., Preiser, J.-C., & ISARIC Clinical Characterisation Group. (2022). Clinical Nutrition (Edinburgh, Scotland), 41(12), 2924-2926.
Casirivimab/Imdevimab for Active COVID-19 Pneumonia Which Persisted for Nine Months in a Patient with Follicular Lymphoma during Anti-CD20 Therapy.
Nagai, H., Saito, M., Adachi, E., Sakai-Tagawa, Y., Yamayoshi, S., Kiso, M., Kawamata, T., Koga, M., Kawaoka, Y., Tsutsumi, T., & Yotsuyanagi, H. (2022). Japanese Journal of Infectious Diseases, 75(6), 608-611.
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Gonçalves, B., Hall, M., Jassat, W., Balan, V., Murthy, S., Kartsonaki, C., Semple, M., Rojek, A., Baruch, J., Reyes, L., Dasgupta, A., Dunning, J., Citarella, B., Pritchard, M., Martín-Quiros, A., Sili, U., Baillie, J., Aryal, D., Arabi, Y., … Olliaro, P. (2022). ELife, 11.
HESITANCY IN COVID-19 VACCINE UPTAKE IN UGANDA: Understanding Community Perceptions in Kampala, Mukono and Wakiso Districts
Kibira, D., Mulumba, M., Nanyonga, S., Baguma, C., Hasunira, R., Nsereko, I., Muhumuza, N., Musoke, J., Ssekamwa, F., & Kakinda, M. (2022). Afya na Haki.
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant.
Halfmann, P., Kuroda, M., Armbrust, T., Theiler, J., Balaram, A., Moreno, G., Accola, M., Iwatsuki-Horimoto, K., Valdez, R., Stoneman, E., Braun, K., Yamayoshi, S., Somsen, E., Baczenas, J., Mitamura, K., Hagihara, M., Adachi, E., Koga, M., McLaughlin, M., … Kawaoka, Y. (2022). Science Translational Medicine, 14(657), eabm4908.
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
Garcia-Gallo, E., Merson, L., Kennon, K., Kelly, S., Citarella, B., Fryer, D., Shrapnel, S., Lee, J., Duque, S., Fuentes, Y., Balan, V., Smith, S., Wei, J., Gonçalves, B., Russell, C., Sigfrid, L., Dagens, A., Olliaro, P., Baruch, J., … Reyes, L. (2022). Scientific Data, 9.
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Guérin, P., McLean, A., Rashan, S., Lawal, A., Watson, J., Strub-Wourgaft, N., & White, N. (2022). PLOS Global Public Health, 2(7).
Anti-spike protein antibody titer at the time of breakthrough infection of SARS-CoV-2 omicron.
Adachi, E., Nagai, E., Saito, M., Isobe, M., Konuma, T., Koga, M., Tsutsumi, T., Nannya, Y., & Yotsuyanagi, H. (2022). Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 28(7), 1015-1017.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.
Uraki, R., Kiso, M., Iida, S., Imai, M., Takashita, E., Kuroda, M., Halfmann, P., Loeber, S., Maemura, T., Yamayoshi, S., Fujisaki, S., Wang, Z., Ito, M., Ujie, M., Iwatsuki-Horimoto, K., Furusawa, Y., Wright, R., Chong, Z., Ozono, S., … Kawaoka, Y. (2022). Nature, 607(7917), 119-127.
Characterizing SARS-CoV-2 viral clearance kinetics to improve the design of antiviral pharmacometric studies
Watson, J., Kissler, S., Day, N., Grad, Y., & White, N. (2022). Antimicrobial Agents and Chemotherapy, 66(7).
Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan.
Adomi, M., Kuno, T., Komiyama, J., Taniguchi, Y., Abe, T., Miyawaki, A., Imai, S., Morita, K., Saito, M., Ohbe, H., Kamio, T., Tamiya, N., & Iwagami, M. (2022). Pharmacoepidemiology and Drug Safety, 31(6), 680-688.
Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV.
Adachi, E., Saito, M., Nagai, H., Ikeuchi, K., Koga, M., Tsutsumi, T., & Yotsuyanagi, H. (2022). Journal of Medical Virology, 94(5), 1789-1791.
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC–WHO clinical characterisation protocol
Wainstein, M., MacDonald, S., Fryer, D., Young, K., Balan, V., Begum, H., Burrell, A., Citarella, B., Cobb, J., Kelly, S., Kennon, K., Lee, J., Merson, L., Murthy, S., Nichol, A., Semple, M., Strudwick, S., Webb, S., Rossignol, P., … Shrapnel, S. (2022). PLOS Medicine, 19(4).
Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization
Mizutani, T., Ishizaka, A., Koga, M., Ikeuchi, K., Saito, M., Adachi, E., Yamayoshi, S., Iwatsuki-Horimoto, K., Yasuhara, A., Kiyono, H., Matano, T., Suzuki, Y., Tsutsumi, T., Kawaoka, Y., & Yotsuyanagi, H. (2022). Microbiology Spectrum, 10(2).
Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan.
Taniguchi, Y., Kuno, T., Komiyama, J., Adomi, M., Suzuki, T., Abe, T., Ishimaru, M., Miyawaki, A., Saito, M., Ohbe, H., Miyamoto, Y., Imai, S., Kamio, T., Tamiya, N., & Iwagami, M. (2022). The Lancet Regional Health. Western Pacific, 20, 100365.